Nothing Special   »   [go: up one dir, main page]

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (23)

Search Parameters:
Keywords = Tinospora cordifolia

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
20 pages, 4072 KiB  
Article
Green Synthesis and Characterization of Silver Nanoparticles from Tinospora cordifolia Leaf Extract: Evaluation of Their Antioxidant, Anti-Inflammatory, Antibacterial, and Antibiofilm Efficacies
by Vijaya Durga V. V. Lekkala, Arun Vasista Muktinutalapati, Veeranjaneya Reddy Lebaka, Dakshayani Lomada, Mallikarjuna Korivi, Wei Li and Madhava C. Reddy
Nanomaterials 2025, 15(5), 381; https://doi.org/10.3390/nano15050381 - 1 Mar 2025
Viewed by 1624
Abstract
The use of metal nanoparticles is gaining popularity owing to their low cost and high efficacy. We focused on green synthesis of silver nanoparticles (AgNPs) using Tinospora cordifolia (Tc) leaf extracts. The structural characteristics of Tc nanoparticles (TcAgNPs) were determined using several advanced [...] Read more.
The use of metal nanoparticles is gaining popularity owing to their low cost and high efficacy. We focused on green synthesis of silver nanoparticles (AgNPs) using Tinospora cordifolia (Tc) leaf extracts. The structural characteristics of Tc nanoparticles (TcAgNPs) were determined using several advanced techniques. Pharmacological activities, including antioxidant, anti-inflammatory, and antibacterial properties, were evaluated through in vitro studies. In the results, the change in sample color from yellow to brown after adding silver nitrate revealed the synthesis of TcAgNPs, and the UV–visible spectrum confirmed their formation. X-ray diffraction studies showed the presence of reducing agents and the crystalline nature of the nanoparticles. Fourier-transform infrared spectra revealed the existence of essential secondary metabolites, which act as reducing/capping agents and stabilize the nanoparticles. The size of the TcAgNPs was small (range 36–168 nm) based on the measurement method. Their negative zeta potential (−32.3 mV) ensured their stability in water suspensions. The TcAgNPs were predominantly spherical, as evidenced from scanning electron microscopy and transmission electron microscopy. Atomic absorption spectroscopy data further revealed the conversion of silver nitrate into silver nanoparticles, and thermogravimetric analysis data showed their thermal stability. The TcAgNPs showed significant DPPH/ABTS radical scavenging ability in a concentration-dependent manner (25–100 µg/mL). Membrane lysis assays showed an effective anti-inflammatory activity of the TcAgNPs. Furthermore, the TcAgNPs showed potent antibacterial effects against multidrug-resistant bacteria (Pseudomonas aeruginosa, Klebsiella pneumonia, Escherichia coli, and Staphylococcus aureus). The TcAgNPs treatment also exhibited antibiofilm activity against bacterial strains, in a concentration-dependent manner. Our findings demonstrate the structural characteristics of green-synthesized TcAgNPs using advanced techniques. TcAgNPs can be developed as potential antioxidant, anti-inflammatory, and antibacterial drugs. Full article
Show Figures

Figure 1

Figure 1
<p>Pictorial illustration of green-synthesis of AgNPs from <span class="html-italic">Tinospora cordifolia</span> leaf extracts.</p>
Full article ">Figure 2
<p>UV-visible spectroscopy of green-synthesized TcAgNPs at different time intervals represented as (<b>a</b>–<b>e</b>), at 2, 4, 6, 12, and 24 h respectively. (<b>e</b>) included with leaf extracts.</p>
Full article ">Figure 3
<p>Structural characteristics of TcAgNPs using (<b>a</b>) XRD, (<b>b</b>) FTIR, (<b>c</b>) DLS (hydrodynamic size), and (<b>d</b>) zeta potential analyses.</p>
Full article ">Figure 4
<p>Structural characteristics of TcAgNPs: (<b>a</b>) scanning electron microscope image: spherical structures of TcAgNPs are labeled with a red outline; (<b>b</b>) energy dispersive X-ray spectrum showing the presence of silver; (<b>c</b>) elemental composition of TcAgNPs from EDX analysis.</p>
Full article ">Figure 5
<p>TEM images and particle size distribution histogram of TcAgNPs at different magnifications.</p>
Full article ">Figure 6
<p>TGA thermograph of <span class="html-italic">T. cordifolia</span> leaf extracts and TcAgNPs.</p>
Full article ">Figure 7
<p>Silver concentration (ppm) in green-synthesized silver nanoparticles.</p>
Full article ">Figure 8
<p>Antioxidant properties of different concentrations of TcAgNPs: (<b>a</b>) DPPH radical scavenging activity and (<b>b</b>) ABTS radical scavenging activity. (<b>c</b>) Anti-inflammatory activity of different concentrations of TcAgNPs. Values expressed as mean ± standard deviation.</p>
Full article ">Figure 9
<p>Zones of inhibition with different concentrations of TcAgNPs against multidrug-resistant (MDR) bacteria: (<b>a</b>) <span class="html-italic">Pseudomonas aeruginosa</span>, (<b>b</b>) <span class="html-italic">Klebsiella pneumonia</span>, (<b>c</b>) <span class="html-italic">Escherichia coli</span>, and (<b>d</b>) <span class="html-italic">Staphylococcus aureus</span>. (<b>e</b>) Graphical presentation of zones of inhibition of TcAgNPs against MDR bacteria. Values are expressed as the mean ± standard deviation.</p>
Full article ">Figure 10
<p>Antibiofilm activity with different concentrations of TcAgNPs: (<b>a</b>) MIC and MBC efficacy of TcAgNPs. (<b>b</b>) Percentage inhibition ability of TcAgNPs and antibiotic against biofilm formation of <span class="html-italic">P. aeruginosa</span>, <span class="html-italic">K. pneumonia</span>, <span class="html-italic">E. coli</span>, and <span class="html-italic">S. aureus.</span> Values are expressed as the mean ± standard deviation.</p>
Full article ">
15 pages, 965 KiB  
Review
Impact of Substance Use Disorder on Tryptophan Metabolism Through the Kynurenine Pathway: A Narrative Review
by Lindsey Contella, Christopher L. Farrell, Luigi Boccuto, Alain H. Litwin and Marion L. Snyder
Metabolites 2024, 14(11), 611; https://doi.org/10.3390/metabo14110611 - 10 Nov 2024
Viewed by 1119
Abstract
Background/Objectives: Substance use disorder is a crisis impacting many people in the United States. This review aimed to identify the effect addictive substances have on the kynurenine pathway. Tryptophan is an essential amino acid metabolized by the serotonin and kynurenine pathways. The [...] Read more.
Background/Objectives: Substance use disorder is a crisis impacting many people in the United States. This review aimed to identify the effect addictive substances have on the kynurenine pathway. Tryptophan is an essential amino acid metabolized by the serotonin and kynurenine pathways. The metabolites of these pathways play a role in the biological reward system. Addictive substances have been shown to cause imbalances in the ratios of these metabolites. With current treatment and therapeutic options being suboptimal, identifying biochemical mechanisms that are impacted during the use of addictive substances can provide alternative options for treatment or drug discovery. Methods: A systematic literature search was conducted to identify studies evaluating the relationship between substance use disorder and tryptophan metabolism through the kynurenine pathway. A total of 32 articles meeting eligibility criteria were used to review the relationship between the kynurenine pathway, tryptophan breakdown, and addictive substances. Results: The use of addictive substances dysregulates tryptophan metabolism and kynurenine metabolite concentrations. This imbalance directly affects the dopamine reward system and is thought to promote continued substance use. Conclusions: Further studies are needed to fully evaluate the metabolites of the kynurenine pathway, along with other options for treatment to repair the metabolite imbalance. Several possible therapeutics have been identified; drugs that restore homeostasis, such as Ro 61-8048 and natural products like Tinospora cordifolia or Decaisnea insignis, are promising options for the treatment of substance use disorder. Full article
(This article belongs to the Section Animal Metabolism)
Show Figures

Figure 1

Figure 1
<p>Metabolism of TRP by the KP. The KP has two main branches: the neurotoxic pathway and the neuroprotective pathway. The impacts addictive substances have on KP metabolites in the blood are shown in grey boxes: + indicates an increase, − decrease, = no change, and § mixed results. Enzymes involved in the pathway are shown in shaded boxes. Abbreviations: EtOH: alcohol; METH: methamphetamine; TRP: tryptophan hydroxylase; AA: aromatic acid; IDO1: indoleamine 2,3-dioxygenase-1; IDO2: indoleamine 2,3-dioxygenase-2; TDO: tryptophan 2,3-dioxygenase; KATs: kynurenine aminotransferases; KMO: kynurenine 3-monooxygenase; KYNU: kynureninase; NE: Nonenzymatic; HAAO: 3-hydroxy anthranilate 3,4-dioxygenase; AFMID: arylformamidase; ACMSD: α-amino-β-carboxymuconate-ε-semialdehyde-decarboxylase; AADAT: aminoadipate aminotransferase; NAD+: nicotinamide adenine dinucleotide.</p>
Full article ">Figure 2
<p>Flow diagram depicting selection of literature included in systematic search using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).</p>
Full article ">
21 pages, 7798 KiB  
Article
Process Optimization of Tinospora cordifolia Extract-Loaded Water in Oil Nanoemulsion Developed by Ultrasound-Assisted Homogenization
by Varisha Anjum, Uday Bagale, Ammar Kadi, Artem Malinin, Irina Potoroko, Amal H. Alharbi, Doaa Sami Khafaga, Marawa AlMetwally, Al-Seyday T. Qenawy, Areefa Anjum and Faraat Ali
Molecules 2024, 29(8), 1797; https://doi.org/10.3390/molecules29081797 - 16 Apr 2024
Cited by 1 | Viewed by 1694
Abstract
Nanoemulsions are gaining interest in a variety of products as a means of integrating easily degradable bioactive compounds, preserving them from oxidation, and increasing their bioavailability. However, preparing stable emulsion compositions with the desired characteristics is a difficult task. The aim of this [...] Read more.
Nanoemulsions are gaining interest in a variety of products as a means of integrating easily degradable bioactive compounds, preserving them from oxidation, and increasing their bioavailability. However, preparing stable emulsion compositions with the desired characteristics is a difficult task. The aim of this study was to encapsulate the Tinospora cordifolia aqueous extract (TCAE) into a water in oil (W/O) nanoemulsion and identify its critical process and formulation variables, like oil (27–29.4 mL), the surfactant concentration (0.6–3 mL), and sonication amplitude (40% to 100%), using response surface methodology (RSM). The responses of this formulation were studied with an analysis of the particle size (PS), free fatty acids (FFAs), and encapsulation efficiency (EE). In between, we have studied a fishbone diagram that was used to measure risk and preliminary research. The optimized condition for the formation of a stable nanoemulsion using quality by design was surfactant (2.43 mL), oil concentration (27.61 mL), and sonication amplitude (88.6%), providing a PS of 171.62 nm, FFA content of 0.86 meq/kg oil and viscosity of 0.597 Pa.s for the blank sample compared to the enriched TCAE nanoemulsion with a PS of 243.60 nm, FFA content of 0.27 meq/kg oil and viscosity of 0.22 Pa.s. The EE increases with increasing concentrations of TCAE, from 56.88% to 85.45%. The RSM response demonstrated that both composition variables had a considerable impact on the properties of the W/O nanoemulsion. Furthermore, after the storage time, the enriched TCAE nanoemulsion showed better stability over the blank nanoemulsion, specially the FFAs, and the blank increased from 0.142 to 1.22 meq/kg oil, while TCAE showed 0.266 to 0.82 meq/kg. Full article
(This article belongs to the Special Issue Current Emerging Trends of Extraction and Encapsulation in Food)
Show Figures

Figure 1

Figure 1
<p>Ishikawa diagrams for (<b>a</b>) the particle size, (<b>b</b>) free fatty acids, and (<b>c</b>) viscosity.</p>
Full article ">Figure 2
<p>(<b>a</b>) Pareto charts of particle size vs. (i) surfactant (ii) oil, and (iii) amplitude. (<b>b</b>) Pareto charts of viscosity vs. (i) surfactant, (ii) oil, and (iii) amplitude. (<b>c</b>) Probability charts of (i) Particle size, (ii) PDI, (iii) free fatty acids, and (iv) viscosity.</p>
Full article ">Figure 3
<p>Response surface and contour plots showing effects of (<b>a</b>) lipid (oil) and surfactant, (<b>b</b>) amplitude and surfactant, and (<b>c</b>) amplitude and lipid (oil) on the PS of W/O nanoemulsions.</p>
Full article ">Figure 4
<p>Response surface and contour plots showing effects of (<b>a</b>) lipid (oil) and surfactant, (<b>b</b>) amplitude and surfactant, and (<b>c</b>) amplitude and lipid (oil) on the PDI of W/O nanoemulsions.</p>
Full article ">Figure 5
<p>Response surface and contour plots showing effects of (<b>a</b>) lipid and surfactant, (<b>b</b>) amplitude and surfactant, and (<b>c</b>) amplitude and lipid on the viscosity of W/O nanoemulsions.</p>
Full article ">Figure 6
<p>Response surface and contour plots showing effects of (<b>a</b>) lipid (oil) and surfactant, (<b>b</b>) amplitude and surfactant, and (<b>c</b>) amplitude and lipid (oil) on FFAs of W/O nanoemulsions.</p>
Full article ">Figure 7
<p>Impact of storage conditions on different properties of the emulsion: (<b>a</b>) PS, (<b>b</b>) PDI, (<b>c</b>) ESI, (<b>d</b>) viscosity, (<b>e</b>) FFAs and PV, and (<b>f</b>) encapsulation efficiency (where Test 1 and Test 2 indicate 100 mM and 200 mM of TCAE, respectively).</p>
Full article ">Figure 8
<p>Scanning electron microscopy and optical microscopy images of optimized nanoemulsions for samples containing (<b>a</b>) 100 mM and (<b>b</b>) 200 mM TCAE.</p>
Full article ">
25 pages, 544 KiB  
Review
Herbal- and Dietary-Supplement-Induced Liver Injury: A Review of the Recent Literature
by Palak A. Patel-Rodrigues, Lindsey Cundra, Dalal Alhaqqan, Daniel T. Gildea, Stephanie M. Woo and James H. Lewis
Livers 2024, 4(1), 94-118; https://doi.org/10.3390/livers4010008 - 13 Feb 2024
Cited by 2 | Viewed by 11989
Abstract
Herbal-induced liver injury (HILI) continues to increase in prevalence each year due to the ongoing popularity of herbal supplements and complementary and alternative medicines. A detailed literature review of case reports and clinical studies published from March 2021 to March 2023 was performed. [...] Read more.
Herbal-induced liver injury (HILI) continues to increase in prevalence each year due to the ongoing popularity of herbal supplements and complementary and alternative medicines. A detailed literature review of case reports and clinical studies published from March 2021 to March 2023 was performed. We discuss the epidemiology and diagnosis of HILI as well as the current and proposed laws and regulations. The 2021 ACG guidelines and 2022 AASLD practice guidelines for the diagnosis and management of drug and herbal-induced liver injury are discussed. We describe updates to previously reported etiologies of HILI such as ayurveda, ashwagandha, turmeric, kratom, green tea extract, and garcinia cambogia. Newly described supplements resulting in HILI, such as tinospora cordifolia, horse chestnut, alkaline water, and more, are described. We discuss newly and previously identified hepatoprotective herbal supplements as they have been reported in the study of animal models and human liver cells. This review suggests the need for ongoing research on the causes and mechanisms of HILI to ensure its proper diagnosis, prevention, and treatment in the future. The goal of this review is to provide novice and expert readers with knowledge regarding the possible etiologies of HILI and a general overview. Full article
Show Figures

Figure 1

Figure 1
<p>Materials and methods.</p>
Full article ">
28 pages, 1550 KiB  
Review
Unveiling Various Facades of Tinospora cordifolia Stem in Food: Medicinal and Nutraceutical Aspects
by Varisha Anjum, Uday Bagale, Ammar Kadi, Irina Potoroko, Shirish H. Sonawane and Areefa Anjum
Molecules 2023, 28(20), 7073; https://doi.org/10.3390/molecules28207073 - 13 Oct 2023
Cited by 6 | Viewed by 3096
Abstract
Natural products with curative properties are gaining immense popularity in scientific and food research, possessing no side effects in contrast to other drugs. Guduchi, or Tinospora cordifolia, belongs to the menispermaceae family of universal drugs used to treat various diseases in traditional [...] Read more.
Natural products with curative properties are gaining immense popularity in scientific and food research, possessing no side effects in contrast to other drugs. Guduchi, or Tinospora cordifolia, belongs to the menispermaceae family of universal drugs used to treat various diseases in traditional Indian literature. It has received attention in recent decades because of its utilization in folklore medicine for treating several disorders. Lately, the findings of active phytoconstituents present in herbal plants and their pharmacological function in disease treatment and control have stimulated interest in plants around the world. Guduchi is ethnobotanically used for jaundice, diabetes, urinary problems, stomachaches, prolonged diarrhea, skin ailments, and dysentery. The treatment with Guduchi extracts was accredited to phytochemical constituents, which include glycosides, alkaloids, steroids, and diterpenoid lactones. This review places emphasis on providing in-depth information on the budding applications of herbal medicine in the advancement of functional foods and nutraceuticals to natural product researchers. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemical structures of active compounds present in <span class="html-italic">T. cordifolia</span> stem.</p>
Full article ">Figure 2
<p>Probable mechanism of action underlying immunomodulation.</p>
Full article ">Figure 3
<p>A pictorial view of the steps involved in addition of <span class="html-italic">T. cordifolia</span> in food products.</p>
Full article ">
17 pages, 3553 KiB  
Article
Phenolic Compounds and Antioxidant and Anti-Enzymatic Activities of Selected Adaptogenic Plants from South America, Asia, and Africa
by Jakub Gębalski, Milena Małkowska, Filip Graczyk, Artur Słomka, Elżbieta Piskorska, Dorota Gawenda-Kempczyńska, Aneta Kondrzycka-Dąda, Anna Bogucka-Kocka, Maciej Strzemski, Ireneusz Sowa, Magdalena Wójciak, Sebastian Grzyb, Krystian Krolik, Aneta A. Ptaszyńska and Daniel Załuski
Molecules 2023, 28(16), 6004; https://doi.org/10.3390/molecules28166004 - 10 Aug 2023
Cited by 7 | Viewed by 1835
Abstract
Despite the fact that there are many studies related to the adaptogenic and pro-healthy activities of plant-based compounds, there are some adaptogenic plants whose activities are not fully known, especially those coming from the wild regions of Asia, Africa, and South America. The [...] Read more.
Despite the fact that there are many studies related to the adaptogenic and pro-healthy activities of plant-based compounds, there are some adaptogenic plants whose activities are not fully known, especially those coming from the wild regions of Asia, Africa, and South America. The aim of these studies was to examine the contents of non-nutritional compounds, such as polyphenols, flavonoids, and phenolic acids in ten adaptogenic species (Astragalus membranaceus (AM), Uncaria rhynchophylla (UR), Polygonum multiflorum (PM), Angelica sinensis (AS), Andrographis paniculatea (AP), Tinospora cordifolia (TC), Uncaria tomentosa (UT), Pfaffia paniculate (PP), Sutherlandia frutescens (SF), and Rhaponticum carthamoides (RC)). Considering biological activity, their antioxidant (DPPH, ABTS, FRAP, and ferrous-ion-chelating ability assays), anti-acetylcholinesterase, anti-hyaluronidase, and anti-tyrosinase activities were evaluated. The richest in polyphenols, flavonoids, and phenolic acids was UR (327.78 mg GAE/g, 230.13 mg QE/g, and 81.03 mg CA/g, respectively). The highest inhibitions of acetylcholinesterase, hyaluronidase, and tyrosinase were observed for TC, UR, and PM, respectively. In the case of antioxidant properties, extract from PM appeared to most strongly reduce DPPH, extract from UR inhibited ABTS, and extract from SF showed the best chelating properties. It should be noted that a particularly interesting plant was Ulcaria rhynchophylla. The results mean that there were compounds in UR with broad biological activities, and this species should be explored in more detail. Additionally, our results justify the traditional use of these species in the nutripharmacological or ethnopharmacological care systems of different regions. Full article
(This article belongs to the Special Issue Natural Antioxidants in Foods and Medicinal Plants)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Antioxidant activities of selected adaptogenic plants via ABTS method. The results are presented as the percentage of inhibition of ABTS radicals.</p>
Full article ">Figure 2
<p>Antioxidant activities of selected adaptogenic plants via DPPH method. The results are presented as the percentage of inhibition of DPPH radicals.</p>
Full article ">Figure 3
<p>Antioxidant activities of selected adaptogenic plants via FRAP method. The results are expressed as mg Trolox equivalent per gram of sample.</p>
Full article ">Figure 4
<p>Inhibition of Fe<sup>2+</sup>–ferrozine formation (%).</p>
Full article ">Figure 5
<p>Activities of extracts against acetylcholinesterase (%).</p>
Full article ">Figure 6
<p>Activities of extracts against tyrosinase (%).</p>
Full article ">Figure 7
<p>Activities of extracts against hyaluronidase (%).</p>
Full article ">Figure 8
<p>Hierarchical cluster analysis of adaptogenic plant samples based on antioxidant activity and enzymatic inhibition.</p>
Full article ">Figure 9
<p>Redundancy analysis (RDA) of the samples of adaptogenic plants based on content of chemical composition, antioxidant activity, and enzymatic inhibition. Eigenvalues: <span class="html-italic">x</span>-axis—0.696, <span class="html-italic">y</span>-axis—0.131, <span class="html-italic">p</span>—0.002 (Monte Carlo test).</p>
Full article ">
23 pages, 5430 KiB  
Article
Regulation of Insulin Resistance, Lipid Profile and Glucose Metabolism Associated with Polycystic Ovary Syndrome by Tinospora cordifolia
by Ritu Rani, Havagiray R. Chitme, Neha Kukreti, Pankaj Pant, Basel A. Abdel-Wahab, Masood Medleri Khateeb, Mohammed Shafiuddin Habeeb and Marwa B. Bakir
Nutrients 2023, 15(10), 2238; https://doi.org/10.3390/nu15102238 - 9 May 2023
Cited by 11 | Viewed by 4029
Abstract
Background: The plant Tinospora cordifolia (TC), traditionally known as guduchi or giloy, is used for a number of health conditions as a nutritional supplement and rejuvenation medicine. Its nutritional supplementary products are traditionally recommended for a wide range of health issues, including diabetes, [...] Read more.
Background: The plant Tinospora cordifolia (TC), traditionally known as guduchi or giloy, is used for a number of health conditions as a nutritional supplement and rejuvenation medicine. Its nutritional supplementary products are traditionally recommended for a wide range of health issues, including diabetes, menstruation discomfort, fever, obesity, inflammation, and more. Unfortunately, there has not been extensive research into its effectiveness in treating or managing insulin resistance, lipid and carbohydrate metabolism, hormonal imbalance, and metabolic syndrome-associated polycystic ovary syndrome (PCOS). Methods: Consequently, the present study was designed to induce insulin resistance, dyslipidemia, hormonal abnormality, hyperglycemia, and menstrual disturbance of PCOS using dehydroepiandrosterone (DHEA) in mice and study the effect of oral TC extracts on these factors by using ancient and modern technologies. During the 21-day study, 6 mg/100 g/day of DHEA was given to female mice. Levels of glucose, insulin, lipids, and hormones were estimated. In addition to being seen with the naked eye, the morphological and microscopic changes were also observed on histology slides. Results: The study outcomes show that pretreatment with TC preparations significantly improved biochemical and histological abnormalities in female mice. Diestrus phase was only observed in DHEA-treated animals, while cornified epithelial cells were present in TC-treated mice. Pretreatment with TC satva showed significant (p < 0.001) reductions in body weight compared to placebo. Fasting blood glucose, 1-h OGTT, and 2-h OGTT levels were all significantly lower in TC satva- and oil-treated animals in comparison to the disease control group (p < 0.001). Treatment with TC extracts resulted in a normalization of estradiol, progesterone, and testosterone levels (p < 0.05). Treatment with TC extract improved lipid profiles (p < 0.001), LH/FSH ratios (p < 0.01), fasting insulin levels (p < 0.001), HOMA-IR (p < 0.001), HOMA-Beta (p < 0.001), and QUICKI (p < 0.001). Both macroscopic and microscopic alterations were seen to be restored after TC extract treatment. After being treated with TC satva, oil, and hydroalcoholic extract, the severity of PCOS decreased by 54.86%. Conclusions: These findings lead us to the conclusion that TC extracts and satva as nutritional supplements are useful for treating PCOS and associated symptoms. It is recommended that additional research be conducted to determine the molecular mechanism of action of TC nutritional supplements on PCOS-related changes in metabolic profiles. We also recommend further clinical studies to explore the clinical efficacy and effectiveness of TC nutritional supplements in treating and/or managing PCOS. Full article
(This article belongs to the Special Issue Nutritional Regulation of Insulin Resistance and Lipid Metabolism)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The different stages of the estrous cycle were estimated in normal healthy mice. (<b>A</b>) In the estrus stage, predominantly cornified epithelial cells (brown arrow) are present. (<b>B</b>) The pro-estrus stage is characterized by nucleated cornified epithelial cells (black arrow) with leukocytes (red arrow). (<b>C</b>) The metestrus stage contains cornified epithelial cells (brown arrow), leukocytes (red arrow), and nucleated epithelial cells (black arrow). (<b>D</b>) In the diestrus stage or PCOS stage, predominantly leukocytes (red arrow) are present.</p>
Full article ">Figure 2
<p>Effects of Tinospora cordifolia extract treatment in DHEA-induced PCOS mice on body weight (<b>A</b>), fasting blood glucose (<b>B</b>), and OGTT (<b>C</b>) measurement. Every value is presented as a mean along with standard error. Data were analyzed by ANOVA followed by DMCT. In all groups, 0 h of OGTT was compared with 1 and 2 h of OGTT. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 3
<p>Treatment with <span class="html-italic">Tinospora cordifolia</span> extracts was given to mice that had DHEA-induced PCOS, and the levels of estradiol (<b>A</b>), progesterone (<b>B</b>), testosterone (<b>C</b>), and LH/FSH (<b>D</b>) were measured. Every value is presented as a mean along with standard error. Data were analyzed by ANOVA followed by DMCT. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 3 Cont.
<p>Treatment with <span class="html-italic">Tinospora cordifolia</span> extracts was given to mice that had DHEA-induced PCOS, and the levels of estradiol (<b>A</b>), progesterone (<b>B</b>), testosterone (<b>C</b>), and LH/FSH (<b>D</b>) were measured. Every value is presented as a mean along with standard error. Data were analyzed by ANOVA followed by DMCT. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 4
<p>Effects of <span class="html-italic">Tinospora cordifolia</span> extract treatment in DHEA-induced PCOS mice on cholesterol (<b>A</b>) and triglyceride (<b>B</b>) levels. Every value is presented as a mean along with standard error. Data were analyzed by ANOVA followed by DMCT. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 5
<p>Effects of <span class="html-italic">Tinospora cordifolia</span> extract treatment in DHEA-induced PCOS mice on fasting insulin levels (<b>A</b>), HOMA-IR (<b>B</b>), HOMA-Beta (<b>C</b>), and QUICKI levels (<b>D</b>). Every value is presented as a mean along with standard error. Data were analyzed by ANOVA followed by DMCT. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 5 Cont.
<p>Effects of <span class="html-italic">Tinospora cordifolia</span> extract treatment in DHEA-induced PCOS mice on fasting insulin levels (<b>A</b>), HOMA-IR (<b>B</b>), HOMA-Beta (<b>C</b>), and QUICKI levels (<b>D</b>). Every value is presented as a mean along with standard error. Data were analyzed by ANOVA followed by DMCT. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 6
<p>The effect that treatment with Tinospora cordifolia extracts had on ovary weight (<b>A</b>) and size (<b>B</b>). Every value is presented as a mean along with standard error. Data were analyzed by ANOVA followed by DMCT. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 7
<p>Effects of <span class="html-italic">Tinospora cordifolia</span> extract treatment in DHEA-induced PCOS mice on morphological examination of the ovaries. Histological analysis of normal ovaries compared with PCOS and ovaries treated with TC preparations. (<b>A</b>) Normal control, (<b>B</b>) DHEA treated, (<b>C</b>) positive control treated by metformin, (<b>D</b>) TC satva 200 mg/kg treated, (<b>E</b>) TC satva 400 mg/kg treated, (<b>F</b>) TC oil 200 mg/kg treated, (<b>G</b>) TC oil 400 mg/kg treated, (<b>H</b>) TC HA 200 mg/kg treated, (<b>I</b>) TC HA 400 mg/kg treated.</p>
Full article ">Figure 8
<p>Effects of TC extracts on histopathology of DHEA-induced PCOS ovaries in mice. Comparative histological examination of normal and PCOS ovarian tissue, as well as ovarian tissue that was treated with TC formulations. Hematoxylin and eosin (H&amp;E) staining, 10× magnification, 100 µM scale, as detailed in <a href="#sec2-nutrients-15-02238" class="html-sec">Section 2</a>. (<b>A</b>) The untreated normal control, (<b>B</b>) the treated positive control with DHEA, (<b>C</b>) the treated positive control with metformin, and (<b>D</b>–<b>I</b>) mice treated with TC satva 200, TC satva 400, TC oil 200, TC oil 400, TC HA 200, and TC HA 400 mg/kg, respectively. AF is short for antral follicle, FC stands for cystic follicle, CL stands for corpus luteum, GC refers to granulosa cell, PF stands for primary follicle, and SF stands for secondary follicle.</p>
Full article ">Figure 8 Cont.
<p>Effects of TC extracts on histopathology of DHEA-induced PCOS ovaries in mice. Comparative histological examination of normal and PCOS ovarian tissue, as well as ovarian tissue that was treated with TC formulations. Hematoxylin and eosin (H&amp;E) staining, 10× magnification, 100 µM scale, as detailed in <a href="#sec2-nutrients-15-02238" class="html-sec">Section 2</a>. (<b>A</b>) The untreated normal control, (<b>B</b>) the treated positive control with DHEA, (<b>C</b>) the treated positive control with metformin, and (<b>D</b>–<b>I</b>) mice treated with TC satva 200, TC satva 400, TC oil 200, TC oil 400, TC HA 200, and TC HA 400 mg/kg, respectively. AF is short for antral follicle, FC stands for cystic follicle, CL stands for corpus luteum, GC refers to granulosa cell, PF stands for primary follicle, and SF stands for secondary follicle.</p>
Full article ">Figure 9
<p>The effect that treatment with Tinospora cordifolia extracts had on severity score for PCOS.</p>
Full article ">
14 pages, 2325 KiB  
Article
Tinosporaside from Tinospora cordifolia Encourages Skeletal Muscle Glucose Transport through Both PI-3-Kinase- and AMPK-Dependent Mechanisms
by Akansha Mishra, Khushbu Sharma, Jyotsana Pandey, Kapil Dev, Sleman Kadan, Mahendra Sahai, Ishbal Ahmad, Arvind K. Srivastava, Akhilesh K. Tamrakar, Hilal Zaid and Rakesh Maurya
Molecules 2023, 28(2), 483; https://doi.org/10.3390/molecules28020483 - 4 Jan 2023
Cited by 6 | Viewed by 3040
Abstract
The stem of Tinospora cordifolia has been traditionally used in traditional Indian systems of medicine for blood sugar control, without the knowledge of the underlying mechanism and chemical constitution responsible for the observed anti-diabetic effect. In the present study, Tinosporaside, a diterpenoid isolated [...] Read more.
The stem of Tinospora cordifolia has been traditionally used in traditional Indian systems of medicine for blood sugar control, without the knowledge of the underlying mechanism and chemical constitution responsible for the observed anti-diabetic effect. In the present study, Tinosporaside, a diterpenoid isolated from the stem of T. cordifolia, was investigated for its effects on glucose utilization in skeletal muscle cells, which was followed by determining the anti-hyperglycemic efficacy in our diabetic db/db mice model. We found that tinosporaside augmented glucose uptake by increasing the translocation of GLUT4 to the plasma membrane in L6 myotubes, upon prolonged exposure for 16 h. Moreover, tinosporaside treatment significantly increased the phosphorylation of protein kinase B/AKT (Ser-473) and 5′ AMP-activated protein kinase (AMPK, Thr-172). These effects were abolished in the presence of the wortmannin and compound C. Administration of tinosporaside to db/db mice improved glucose tolerance and peripheral insulin sensitivity associated with increased gene expression and phosphorylation of the markers of phosphoinositide 3-kinases (PI3Ks) and AMPK signaling in skeletal muscle tissue. The findings revealed that tinosporaside exerted its antidiabetic efficacy by enhancing the rate of glucose utilization in skeletal muscle, mediated by PI3K- and AMPK-dependent signaling mechanisms. Full article
(This article belongs to the Special Issue Phytochemical and Pharmacological Evaluation of Natural Products)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemical structure of tinosporaside, isolated from the stem of <span class="html-italic">Tinospora cordifolia</span>.</p>
Full article ">Figure 2
<p>Dose- and time-dependent effect of tinosporaside on glucose uptake. (<b>a</b>) L6 myotubes were treated with different concentrations of tinosporaside for 16 h. After incubation, a subset of cells were stimulated with 100 nM of insulin for 20 min, which was followed by the determination of 2-DG uptake. (<b>b</b>) L6 myotubes were treated at 10 µM concentration of tinosporaside for a different time period and 2-DG uptake was determined in absence (white bars) or presence of 100 nM insulin (black bars). (<b>c</b>) L6 cells were treated with tinosporaside for 24 h at different concentrations, from 5 µM to 100 µM, and cytotoxicity was measured using the MTT assay. Results are expressed as fold stimulation over control basal. Results shown are mean ± SE of three independent experiments. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, relative to control basal.</p>
Full article ">Figure 3
<p>Dose-dependent effect of tinosporaside on GLUT4<span class="html-italic">myc</span> translocation in L6-GLUT4<span class="html-italic">myc</span> myotubes. Cells were incubated with 10 μM and 20 μM concentrations of tinosporaside for 16 h, with the final three hours in a serum-deprived medium. After incubation, myotubes were left untreated (white bars) or stimulated with 100 nM insulin (black bars) for 20 min, which was followed by the determination of the proportion of GLUT4<span class="html-italic">myc</span> at the cell surface. Results are expressed as fold stimulation over control basal. Results shown are mean ± SE of three independent experiments, each performed in triplicate. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, relative to respective control condition.</p>
Full article ">Figure 4
<p>Effect of wortmannin on tinosporaside-induced glucose uptake in L6 myotubes: Cells were incubated in the absence (Control) or the presence of tinosporaside (10 μM) for 16 h without or with wortmannin (100 nM). After incubation, myotubes were left untreated (white bars) or stimulated with 100 nM insulin (black bars) for 20 min, which was followed by the determination of the glucose uptake. Results are expressed as fold stimulation over control basal and performed in triplicate. Results shown are mean ± SE of three independent experiments. ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, relative to control basal; <sup><span>$</span><span>$</span></sup> <span class="html-italic">p</span> &lt; 0.01, relative to control insulin-treated group; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01, relative to basal tinosporaside-treated group; <sup>δ</sup> <span class="html-italic">p</span> &lt; 0.05 relative to tinosporaside insulin-treated group.</p>
Full article ">Figure 5
<p>Effect of Compound C on tinosporaside-induced glucose uptake in L6 myotubes. L6 myotubes were treated with tinosporaside in the absence or presence of compound C for 30 min, which was followed by the determination of 2-DG uptake. Results shown are mean ± SE of three independent experiments. ** <span class="html-italic">p</span> &lt; 0.01, relative to control; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01, relative to the tinosporaside treated group.</p>
Full article ">Figure 6
<p>Antidiabetic effect of tinosporaside in C57BL-Ks db/db mice. Mice were treated daily with tinosporaside for15 consecutive days and blood glucose levels were monitored daily. Shown above are effects on postprandial blood glucose levels (<b>a</b>), OGTT at day 10 and day 15 (<b>b</b>), fasting blood glucose (<b>c</b>), serum insulin level (<b>d</b>), HOMA-index (<b>e</b>), and serum lipid profile (<b>f</b>). Data are expressed as the mean ± SE value, <span class="html-italic">n</span> = 5. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, relative to control animals.</p>
Full article ">Figure 7
<p>Effect of tinosporaside on gene expression of diabetes-related genes in muscle tissues of C57BL-Ks db/db mice. Skeletal muscle tissues were excised, RNA was isolated from the control and tinosporaside-treated mice, which was followed by real-time PCR for determination of the expression profiling of the indicated genes. Results are expressed as the mean ± SE, <span class="html-italic">n</span> = 3. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, relative to control group.</p>
Full article ">Figure 8
<p>Tinosporaside-stimulated glucose uptake is mediated by activation of PI3K/AKT- and AMPK-dependent pathways. Western blot analysis of phospho-IRS-1, phospho-Akt, Akt and GLUT4 (<b>a</b>), phospho-AMPK (<b>b</b>) and p38 MAPK (<b>c</b>) in skeletal muscle of db/db mice treated with vehicle (white bars) or tinosporaside (Black bars) are presented. Results are expressed as the mean ± SE. ** <span class="html-italic">p</span> &lt; 0.01, relative to control condition.</p>
Full article ">
18 pages, 1808 KiB  
Article
In Vitro and In Silico Studies for the Identification of Potent Metabolites of Some High-Altitude Medicinal Plants from Nepal Inhibiting SARS-CoV-2 Spike Protein
by Saroj Basnet, Rishab Marahatha, Asmita Shrestha, Salyan Bhattarai, Saurav Katuwal, Khaga Raj Sharma, Bishnu P. Marasini, Salik Ram Dahal, Ram Chandra Basnyat, Simon G. Patching and Niranjan Parajuli
Molecules 2022, 27(24), 8957; https://doi.org/10.3390/molecules27248957 - 15 Dec 2022
Cited by 5 | Viewed by 3772
Abstract
Despite ongoing vaccination programs against COVID-19 around the world, cases of infection are still rising with new variants. This infers that an effective antiviral drug against COVID-19 is crucial along with vaccinations to decrease cases. A potential target of such antivirals could be [...] Read more.
Despite ongoing vaccination programs against COVID-19 around the world, cases of infection are still rising with new variants. This infers that an effective antiviral drug against COVID-19 is crucial along with vaccinations to decrease cases. A potential target of such antivirals could be the membrane components of the causative pathogen, SARS-CoV-2, for instance spike (S) protein. In our research, we have deployed in vitro screening of crude extracts of seven ethnomedicinal plants against the spike receptor-binding domain (S1-RBD) of SARS-CoV-2 using an enzyme-linked immunosorbent assay (ELISA). Following encouraging in vitro results for Tinospora cordifolia, in silico studies were conducted for the 14 reported antiviral secondary metabolites isolated from T. cordifolia—a species widely cultivated and used as an antiviral drug in the Himalayan country of Nepal—using Genetic Optimization for Ligand Docking (GOLD), Molecular Operating Environment (MOE), and BIOVIA Discovery Studio. The molecular docking and binding energy study revealed that cordifolioside-A had a higher binding affinity and was the most effective in binding to the competitive site of the spike protein. Molecular dynamics (MD) simulation studies using GROMACS 5.4.1 further assayed the interaction between the potent compound and binding sites of the spike protein. It revealed that cordifolioside-A demonstrated better binding affinity and stability, and resulted in a conformational change in S1-RBD, hence hindering the activities of the protein. In addition, ADMET analysis of the secondary metabolites from T. cordifolia revealed promising pharmacokinetic properties. Our study thus recommends that certain secondary metabolites of T. cordifolia are possible medicinal candidates against SARS-CoV-2. Full article
(This article belongs to the Special Issue Biophysical Chemistry)
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Percentage inhibition of hACE2 binding with S1-RBD exhibited by plant extracts (5 mg/mL); (<b>b</b>) binding curve of hACE2 receptor to S1-RBD protein of SARS-CoV-2 in the presence of a range of crude extracts from <span class="html-italic">T. cordifolia</span> as determined by ELISA. The data represent mean ± SEM from <span class="html-italic">n</span> = 3 samples.</p>
Full article ">Figure 2
<p>Interacting residues and the type of interactions of SARS-CoV-2 S1-RBD with (<b>a</b>) cordifolioside A and (<b>b</b>) palmitoside G; (<b>c</b>) 3D interaction of cordifolioside-A with SARS-CoV-2-S1-RBD; and (<b>d</b>) 2D interaction of cordifolioside A with SARS-CoV-2-S1-RBD obtained from Molecular Operating Environment (MOE).</p>
Full article ">Figure 3
<p>(<b>a</b>) RMSD of the atomic positions for the free S1-RBD and S1-RBD-cordifolioside A; (<b>b</b>) RMSF of the atomic positions for the free S1-RBD and S1-RBD-cordifolioside A; (<b>c</b>) radius of gyration for the free S1-RBD and S1-RBD-cordifolioside A for 200 ns MD simulation using GROMACS package.</p>
Full article ">Figure 4
<p>Chemical structures of secondary metabolites with antiviral activities from <span class="html-italic">T. cordifolia</span>.</p>
Full article ">Figure 5
<p>Workflow of the present study.</p>
Full article ">
16 pages, 4210 KiB  
Article
Biosynthesis of Gold Nanoparticles and Its Effect against Pseudomonas aeruginosa
by Syed Ghazanfar Ali, Mohammad Jalal, Hilal Ahmad, Khalid Umar, Akil Ahmad, Mohammed B. Alshammari and Haris Manzoor Khan
Molecules 2022, 27(24), 8685; https://doi.org/10.3390/molecules27248685 - 8 Dec 2022
Cited by 9 | Viewed by 2573
Abstract
Antimicrobial resistance has posed a serious health concern worldwide, which is mainly due to the excessive use of antibiotics. In this study, gold nanoparticles synthesized from the plant Tinospora cordifolia were used against multidrug-resistant Pseudomonas aeruginosa. The active components involved in the [...] Read more.
Antimicrobial resistance has posed a serious health concern worldwide, which is mainly due to the excessive use of antibiotics. In this study, gold nanoparticles synthesized from the plant Tinospora cordifolia were used against multidrug-resistant Pseudomonas aeruginosa. The active components involved in the reduction and stabilization of gold nanoparticles were revealed by gas chromatography–mass spectrophotometry(GC-MS) of the stem extract of Tinospora cordifolia. Gold nanoparticles (TG-AuNPs) were effective against P. aeruginosa at different concentrations (50,100, and 150 µg/mL). TG-AuNPs effectively reduced the pyocyanin level by 63.1% in PAO1 and by 68.7% in clinical isolates at 150 µg/mL; similarly, swarming and swimming motilities decreased by 53.1% and 53.8% for PAO1 and 66.6% and 52.8% in clinical isolates, respectively. Biofilm production was also reduced, and at a maximum concentration of 150 µg/mL of TG-AuNPs a 59.09% reduction inPAO1 and 64.7% reduction in clinical isolates were observed. Lower concentrations of TG-AuNPs (100 and 50 µg/mL) also reduced the pyocyanin, biofilm, swarming, and swimming. Phenotypically, the downregulation of exopolysaccharide secretion from P. aeruginosa due to TG-AuNPs was observed on Congo red agar plates Full article
Show Figures

Figure 1

Figure 1
<p>SEM image of TG-AuNPs.</p>
Full article ">Figure 2
<p>(<b>A</b>) TEM image of TG-AuNPs; (<b>B</b>) Particle size distribution of TG-AuNPs.</p>
Full article ">Figure 3
<p>XRD of TG-AuNPs.</p>
Full article ">Figure 4
<p>Representative GC-MS chromatogram of stem extract of <span class="html-italic">Tinospora cordifolia</span>.</p>
Full article ">Figure 5
<p>Representative of treated and untreated culture of PAO1 with TG-AuNPs: (<b>A</b>) pyocyanin; (<b>B</b>) biofilm; (<b>C</b>) motility (swarm and swim). For pyocyanin and biofilm 50, 100, and 150 µg/mL concentrations of TG-AuNPs were considered, whereas for motility only a 150 µg/mL of concentration of TG-AuNP was considered. Pyocyanin expressed as µg/mL. Absorbance measured at 595 nm. Swarm and Swim expressed as zone size in mm.</p>
Full article ">Figure 6
<p>Bar graphs representative of level of pyocyanin after treatment of clinical isolates of <span class="html-italic">P. aeruginosa</span> with TG-AuNPs at 50, 100 and 150 µg/mL, along with control (untreated). Pyocyanin expressed as µg/mL.</p>
Full article ">Figure 7
<p>Bar graphs representative of swarm and swim after treatment of clinical isolates of <span class="html-italic">P. aeruginosa</span> with TG-AuNPsat150 µg/mL, along with control (untreated). Swarm and Swim expressed as zone size in mm.</p>
Full article ">Figure 8
<p>Representative of swarming of <span class="html-italic">P. aeruginosa</span>. (<b>A</b>) Swarm of PAO1. (<b>B</b>) Swarm of PAO1 after treatment with 150 µg/mL of TG-AuNPs. (<b>C</b>) Swarm of clinical isolate of <span class="html-italic">P. aeruginosa</span>. (<b>D</b>) Swarm of clinical isolate of <span class="html-italic">P. aeruginosa</span> after treatment with 150 µg/mL of TG-AuNPs.</p>
Full article ">Figure 9
<p>Representative of swimming of <span class="html-italic">P. aeruginosa</span>. (<b>A</b>) Swim of PAO1. (<b>B</b>) Swim of PAO1 after treatment with 150 µg/mL of TG-AuNPs. (<b>C</b>) Swim of clinical isolate of <span class="html-italic">P. aeruginosa</span>. (<b>D</b>) Swim of clinical isolate of <span class="html-italic">P. aeruginosa</span> after treatment with 150 µg/mL of TG-AuNPs.</p>
Full article ">Figure 10
<p>Bar graphs representative of biofilm after treatment of clinical isolates of <span class="html-italic">P. aeruginosa</span> with TG-AuNPs at 50,100, and 150 µg/mL, along with control (untreated). Absorbance measured at 595 nm.</p>
Full article ">Figure 11
<p>Representative of biofilm of <span class="html-italic">P. aeruginosa</span> on Congo red agar. Black coloration represents production of exopolysaccharide. (<b>A</b>) Biofilm of PAO1. (<b>B</b>) Biofilm of PAO1 after treatment with 150 µg/mL of TG-AuNPs. (<b>C</b>) Biofilm of clinical isolate of <span class="html-italic">P. aeruginosa</span>. (<b>D</b>) Biofilm of clinical isolate of <span class="html-italic">P. aeruginosa</span> after treatment with 150 µg/mL of TG-AuNPs.</p>
Full article ">
15 pages, 4219 KiB  
Article
Phytoconstituents Assisted Biofabrication of Copper Oxide Nanoparticles and Their Antiplasmodial, and Antilarval Efficacy: A Novel Approach for the Control of Parasites
by Chidambaram Jayaseelan, Ahmed Abdulhaq, Chinnasamy Ragavendran and Syam Mohan
Molecules 2022, 27(23), 8269; https://doi.org/10.3390/molecules27238269 - 27 Nov 2022
Cited by 6 | Viewed by 2003
Abstract
The present work aimed to biofabricate copper oxide nanoparticles (CuO NPs) using Tinospora cordifolia leaf extract. The biofabricated CuO NPs were treated against the malarial parasite of chloroquine-resistant Plasmodium falciparum (INDO) and the antilarval efficacy was evaluated against the malaria vector Anopheles stephensi [...] Read more.
The present work aimed to biofabricate copper oxide nanoparticles (CuO NPs) using Tinospora cordifolia leaf extract. The biofabricated CuO NPs were treated against the malarial parasite of chloroquine-resistant Plasmodium falciparum (INDO) and the antilarval efficacy was evaluated against the malaria vector Anopheles stephensi and dengue vector Aedes aegypti. The prominence at 285 nm in the UV–visible spectrum helped to identify the produced CuO NPs. Based on the XRD patterns, the concentric rings correspond to reflections at 38.26° (111), 44.11° (200), 64.58° (220), and 77.34° (311). These separations are indicative of CuO’s face-centered cubic (fcc) structure. The synthesized CuO NPs have FTIR spectra with band intensities of 3427, 2925, 1629, 1387, 1096, and 600 cm−1. The absorbance band at 3427 cm−1 is known to be associated with the stretching O-H due to the alcoholic group. FTIR proved that the presence of the -OH group is responsible for reducing and capping agents in the synthesis of nanoparticles (NPs). The synthesized CuO NPs were found to be polymorphic (oval, elongated, and roughly spherical) in form with a size range of 11–47 nm and an average size of 16 nm when the morphology was examined using FESEM and HRTEM. The highest antiplasmodial efficacy against the chloroquine-resistant strain of P. falciparum (INDO) was found in the synthesized CuO NPs, with LC50 values of 19.82 µg/mL, whilst HEK293 cells are the least toxic, with a CC50 value of 265.85 µg/mL, leading to a selectivity index of 13.41. However, the antiplasmodial activity of T. cordifolia leaf extract (TCLE) and copper sulfate (CS) solution showed moderate activity, with LC50 values of 52.24 and 63.88 µg/mL, respectively. The green synthesized NPs demonstrated extremely high antilarval efficacy against the larvae of An. stephensi and Ae. aegypti, with LC50 values of 4.06 and 3.69 mg/L, respectively. Full article
(This article belongs to the Special Issue Natural Compounds in Modern Therapies)
Show Figures

Figure 1

Figure 1
<p>UV–visible absorption spectra of synthesized CuO NPs.</p>
Full article ">Figure 2
<p>XRD spectra of synthesized CuO NPs.</p>
Full article ">Figure 3
<p>FTIR spectra of synthesized CuO NPs.</p>
Full article ">Figure 4
<p>FESEM images of synthesized CuO NPs at (<b>A</b>) 60,000× and (<b>B</b>) 150,000× magnifications.</p>
Full article ">Figure 5
<p>EDX spectra of synthesized CuO NPs.</p>
Full article ">Figure 6
<p>The TEM images of CuO NPs (<b>A</b>,<b>B</b>) showing morphology and (<b>C</b>) particle size distribution.</p>
Full article ">Figure 7
<p>Antiplasmodial effect of biofabricated copper oxide nanoparticles (CuO NPs), <span class="html-italic">T. cordifolia</span> leaf extract (TCLE), and copper sulfate (CS) solution.</p>
Full article ">Figure 8
<p>Cytotoxic effect of biofabricated copper oxide nanoparticles (CuO NPs), <span class="html-italic">T. cordifolia</span> leaf extract (TCLE), and copper sulfate (CS) solution.</p>
Full article ">
15 pages, 1952 KiB  
Article
Molecular Characterization of Tinospora cordifolia (Willd.) Miers Using Novel g-SSR Markers and Their Comparison with EST-SSR and SCoT Markers for Genetic Diversity Study
by Ritu Paliwal, Rakesh Singh, Debjani Roy Choudhury, Gunjan Tiwari, Ashok Kumar, K. C. Bhat and Rita Singh
Genes 2022, 13(11), 2042; https://doi.org/10.3390/genes13112042 - 5 Nov 2022
Cited by 11 | Viewed by 2536
Abstract
In the present study, novel genomic-SSR (g-SSR) markers generated in our laboratory were used to characterize Tinospora cordifolia and related species. The g-SSR marker was also compared with EST-SSR and SCoT markers used earlier in our laboratory to assess the genetic diversity of [...] Read more.
In the present study, novel genomic-SSR (g-SSR) markers generated in our laboratory were used to characterize Tinospora cordifolia and related species. The g-SSR marker was also compared with EST-SSR and SCoT markers used earlier in our laboratory to assess the genetic diversity of T. cordifolia. A total of 26 accessions of T. cordifolia and 1 accession each of Tinospora rumphii and Tinospora sinensis were characterized using 65 novel g-SSR markers. A total of 125 alleles were detected with 49 polymorphic g-SSR markers. The number of alleles per locus varied from 1–4 with a mean value of 2.55 alleles per locus. Mean PIC, gene diversity, and heterozygosity were estimated to be 0.33, 0.41, and 0.65, respectively. The two species, namely T. rumphii and T. sinensis, showed cross-species transferability of g-SSRs developed in T. cordifolia. The success rate of cross-species transferability in T. rumphii was 95.3% and 93.8% in T. sinensis, proving the usefulness of this marker in genetic diversity studies of related species. The Tinospora accessions were also used for molecular characterization using SCoT and EST-SSR markers and compared for genetic diversity and cross-species transferability. The PIC, gene diversity, heterozygosity, and principal coordinate analysis showed that g-SSR is the better maker for a genetic diversity study of T. cordifolia. Additionally, high cross-species transferability of g-SSRs was found (95.3% and 93.8%) compared to EST-SSRs (68.8% and 67.7%) in T. rumphii and T. sinensis, respectively. Full article
(This article belongs to the Special Issue Phylogenetics, Genetics, and Breeding of Medicinal Plants)
Show Figures

Figure 1

Figure 1
<p>Genetic relationships study among 28 <span class="html-italic">Tinospora</span> accessions based on (<b>a</b>) g-SSR, (<b>b</b>) EST-SSR, and (<b>c</b>) SCoT markers.</p>
Full article ">Figure 2
<p>STRUCTURE bar plots of (<b>a</b>) g SSR (K = 2), (<b>b</b>) EST-SSR (K = 3), and (<b>c</b>) SCoT (K = 3) of 28 accessions of <span class="html-italic">Tinospora</span>.</p>
Full article ">Figure 3
<p>Principal Coordinate Analysis (PCoA) of 28 <span class="html-italic">Tinospora</span> accessions based on (<b>a</b>) g-SSR (<b>b</b>) EST-SSR (<b>c</b>) SCoT markers.</p>
Full article ">Figure 4
<p>Analysis of Molecular variance (AMOVA) of 28 accessions of <span class="html-italic">Tinospora</span> based on (<b>a</b>) g-SSR (<b>b</b>) EST-SSR (<b>c</b>) SCoT markers.</p>
Full article ">Figure 5
<p>(<b>a</b>) Comparison of g-SSR, EST-SSR, and SCoT markers on diversity parameters of 28 <span class="html-italic">Tinospora</span> accessions. (<b>b</b>) Comparison of percent polymorphism between g-SSR, EST-SSR, and SCoT markers of 28 <span class="html-italic">Tinospora</span> accessions.</p>
Full article ">Figure 5 Cont.
<p>(<b>a</b>) Comparison of g-SSR, EST-SSR, and SCoT markers on diversity parameters of 28 <span class="html-italic">Tinospora</span> accessions. (<b>b</b>) Comparison of percent polymorphism between g-SSR, EST-SSR, and SCoT markers of 28 <span class="html-italic">Tinospora</span> accessions.</p>
Full article ">Figure 6
<p>Comparison of cross-species transferability rate in <span class="html-italic">Tinospora rumphii</span> and <span class="html-italic">Tinospora sinensis</span> by using g-SSR and EST-SSR markers.</p>
Full article ">
22 pages, 2987 KiB  
Article
Potential Epha2 Receptor Blockers Involved in Cerebral Malaria from Taraxacum officinale, Tinospora cordifolia, Rosmarinus officinalis and Ocimum basilicum: A Computational Approach
by Mohd Sayeed Shaikh, Fahadul Islam, Parag P. Gargote, Rutuja R. Gaikwad, Kalpana C. Dhupe, Sharuk L. Khan, Falak A. Siddiqui, Ganesh G. Tapadiya, Syed Sarfaraz Ali, Abhijit Dey and Talha Bin Emran
Pathogens 2022, 11(11), 1296; https://doi.org/10.3390/pathogens11111296 - 4 Nov 2022
Cited by 7 | Viewed by 2366
Abstract
Cerebral malaria (CM) is a severe manifestation of parasite infection caused by Plasmodium species. In 2018, there were approximately 228 million malaria cases worldwide, resulting in about 405,000 deaths. Survivors of CM may live with lifelong post-CM consequences apart from an increased risk [...] Read more.
Cerebral malaria (CM) is a severe manifestation of parasite infection caused by Plasmodium species. In 2018, there were approximately 228 million malaria cases worldwide, resulting in about 405,000 deaths. Survivors of CM may live with lifelong post-CM consequences apart from an increased risk of childhood neurodisability. EphA2 receptors have been linked to several neurological disorders and have a vital role in the CM-associated breakdown of the blood–brain barrier. Molecular docking (MD) studies of phytochemicals from Taraxacum officinale, Tinospora cordifolia, Rosmarinus officinalis, Ocimum basilicum, and the native ligand ephrin-A were conducted to identify the potential blockers of the EphA2 receptor. The software program Autodock Vina 1.1.2 in PyRx-Virtual Screening Tool and BIOVIA Discovery Studio visualizer was used for this MD study. The present work showed that blocking the EphA2 receptor by these phytochemicals prevents endothelial cell apoptosis by averting ephrin-A ligand-expressing CD8+ T cell bioadhesion. These phytochemicals showed excellent docking scores and binding affinity, demonstrating hydrogen bond, electrostatic, Pi-sigma, and pi alkyl hydrophobic binding interactions when compared with native ligands at the EphA2 receptor. The comparative MD study using two PDB IDs showed that isocolumbin, carnosol, luteolin, and taraxasterol have better binding affinities (viz. −9.3, −9.0, −9.5, and −9.2 kcal/mol, respectively). Ocimum basilicum phytochemicals showed a lower docking score but more binding interactions than native ligands at the EphA2 receptor for both PDB IDs. This suggests that these phytochemicals may serve as potential drug candidates in the management of CM. We consider that the present MD study provides leads in drug development by targeting the EphA2 receptor in managing CM. The approach is innovative because a role for EphA2 receptors in CM has never been highlighted. Full article
(This article belongs to the Special Issue Infectious Diseases and Vaccine Technology Research)
Show Figures

Figure 1

Figure 1
<p>EphA2-associated cellular biochemical mechanism of development of CM. (1) iRBCs directed signaling through EPCR, ICAM-1, and UNK receptors lead to endothelial activation. (2) Release of various pro-inflammatory cytokines (LT-α and TNF-α and chemokine (CXCL10 and CCL2). (3) The cytokine LT-α can act on proximal endothelial cells to induce upregulation of the receptor EphA2. (4) TNF-α induces upregulation of ephrin-A1 ligand, which can be cleaved by metalloproteinases and is released into the bloodstream. (5) Chemokines such as CXCL10 and CCL2 recruit circulating immune cells, including CD8+ T cells, to the brain to the site of inflammation. (7) Ephrin-A1 ligand is then adhered to newly recruited CD8+ T cells and considered as ephrin-A1 ligand expressing CD8+ T cells. (7) Upon entry into the brain microvasculature, CD8+ T cells expressing the ephrin-A1 ligand bind to the EphA2 receptor expressed on brain endothelial cells leading to clustering and activation of EphA2. Forward signaling cascades from the EphA2 receptor led to the activation of the NF-κB pathway. (8) This results in various downstream consequences, including disruption of endothelial cell junctions due to both internalization and shedding of different adherents and tight junction protein components. (8) Once brain endothelial cell junctions are disrupted, contents of the vasculature can leak into the brain parenchyma. (9) This leads to vascular leakage, brain edema, and the development of other neurological symptoms associated with <span class="html-italic">P. falciparum</span> infection in CM (Modified diagram of Darling et al. 2020) [<a href="#B13-pathogens-11-01296" class="html-bibr">13</a>].</p>
Full article ">Figure 2
<p>Pathogenesis of development and prevention of CM.</p>
Full article ">Figure 3
<p>2D and 3D docking poses of native ligand (<b>a</b>,<b>f</b>) and phytoconstituents [Methyl Eugenol (<b>b</b>,<b>g</b>); Palmatine (<b>c</b>,<b>h</b>); Carnosic Acid (<b>d</b>,<b>i</b>); Luteolin (<b>e</b>,<b>j</b>)] with Receptor-binding Domain (RBD) of EphA2 (PDB ID: 6FNH).</p>
Full article ">Figure 3 Cont.
<p>2D and 3D docking poses of native ligand (<b>a</b>,<b>f</b>) and phytoconstituents [Methyl Eugenol (<b>b</b>,<b>g</b>); Palmatine (<b>c</b>,<b>h</b>); Carnosic Acid (<b>d</b>,<b>i</b>); Luteolin (<b>e</b>,<b>j</b>)] with Receptor-binding Domain (RBD) of EphA2 (PDB ID: 6FNH).</p>
Full article ">Figure 4
<p>2D and 3D docking poses of the native ligand (<b>a</b>,<b>f</b>) and phytochemicals [Methyl Eugenol (<b>b</b>,<b>g</b>); Palmatine (<b>c</b>,<b>h</b>); Carnosic Acid (<b>d</b>,<b>i</b>); Luteolin (<b>e</b>,<b>j</b>)] with Receptor-binding Domain (RBD) of EphA2 (PDB ID: 5NK0).</p>
Full article ">Figure 4 Cont.
<p>2D and 3D docking poses of the native ligand (<b>a</b>,<b>f</b>) and phytochemicals [Methyl Eugenol (<b>b</b>,<b>g</b>); Palmatine (<b>c</b>,<b>h</b>); Carnosic Acid (<b>d</b>,<b>i</b>); Luteolin (<b>e</b>,<b>j</b>)] with Receptor-binding Domain (RBD) of EphA2 (PDB ID: 5NK0).</p>
Full article ">
22 pages, 4377 KiB  
Article
Augmentation and Evaluation of an Olive Oil Based Polyherbal Combination against Diabetic Cardiomyopathy in Experimental Model of Rodents
by Arshiya Shamim, Hefazat H. Siddiqui, Tarique Mahmood, Tanveer A. Wani, Seema Zargar, Mohammad Haris Siddiqui, Alvina Farooqui, Farogh Ahsan, Mohammad Shariq, Saba Parveen, Muhammad Wahajuddin, Pranay Wal and Akash Ved
Diabetology 2022, 3(4), 561-582; https://doi.org/10.3390/diabetology3040043 - 2 Nov 2022
Cited by 2 | Viewed by 2479
Abstract
Diabetes mellitus is a metabolic disorder that is prima facie a cause for numerous macro and micro vascular complications. A common macroscopic complication associated with diabetes is cardiomyopathy. Cardiomyopathy refers to diseases of the heart muscle, where the heart muscle becomes enlarged, thick, [...] Read more.
Diabetes mellitus is a metabolic disorder that is prima facie a cause for numerous macro and micro vascular complications. A common macroscopic complication associated with diabetes is cardiomyopathy. Cardiomyopathy refers to diseases of the heart muscle, where the heart muscle becomes enlarged, thick, or rigid. As cardiomyopathy worsens, the heart becomes weaker and is unable to conduct the right amount of blood through the body and maintain a normal electrical rhythm. This can lead to heart failure or arrhythmias. Chronic diabetes is one of the instigating factors behind the etiology of this cardiac complication. Type-II diabetes is associated with impaired glucose metabolism that increases the dependence of a diabetic heart on fatty acid oxidation to meet its functional demands, resulting in mitochondrial uncoupling, glucotoxicity, lipotoxicity and initially subclinical cardiac dysfunction that finally gives way to heart failure. The increasing diabetic population with cardiac disorders and the ironically decreasing trend in newer medications to counter this complication leave us at a crossroads for pharmacological management of diabetic cardiomyopathy. Keeping this in view, the present study proclaims a newly developed polyherbal combination (PHC) with three herbs, namely Tinospora cordifolia, Withania somnifera and Boerhavia diffusa based in olive oil and administered in fixed dose (PHC-6 and PHC-10) to screen its cardioprotective potential against a well-established experimental model for diabetic cardiomyopathy. The three herbs mentioned have been known through the traditional literature for their antidiabetic and cardioprotective roles, hence they became the obvious choice. The study follows an experimental model proposed by Reed et al., where the capacity of the β-cell is unobtrusively impeded without totally compromising insulin release, bringing about a moderate disability in glucose resilience. Various sophisticated parameters, namely intraventricular septum thickness of hearts, Western blot of α/β- MHC monoclonal antibody (Ab), cardiac pyruvate dehydrogenase (PDH) activity, medium chain acyl coenzyme A dehydrogenase (MCAD) enzyme, etc. showed promising results where treatment with PHC (PHC-6 and PHC-10) significantly (*** p < 0.001 and **** p < 0.0001) prevented the symptoms of cardiomyopathy in subsequent groups when compared to disease control group. Full article
(This article belongs to the Special Issue Nutrition, Lifestyles, and Metabolomics in Diabetes)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Initial and final blood glucose levels. All values are expressed as mean ± SD (<italic>n</italic> = 6) analyzed by one way ANOVA followed by Tukey’s <italic>t</italic>-test. D-HFD-C was compared with NC (<sup>#</sup> <italic>p</italic> &lt; 0.0001) and the results were found to be highly significantly different, whereas the different treatment groups were compared with D-HFD-C, and the results were found to be different at significance levels <sup>d</sup> <italic>p</italic> &lt; 0.05; <sup>a</sup> <italic>p</italic> &lt; 0.0001. NC is normal control; D-HFD-C is diabetic high-fat diet control group; PHC6 and PHC10 are polyherbal combination treated groups.</p>
Full article ">Figure 2
<p>All values are expressed as mean ± SD (<italic>n</italic> = 6) analyzed by one-way ANOVA followed by Tukey’s <italic>t</italic>-test. D-HFD-C was compared with NC (<sup>#</sup> <italic>p</italic> &lt; 0.0001), and the result was found to be highly significantly different. The different treatment groups were compared with D-HFD-C, and the results were found to be different at the significance levels ** <italic>p</italic> &lt; 0.01 and **** <italic>p</italic> &lt; 0.0001. NC is normal control; D-HFD-C is diabetic high-fat diet control group; PHC6 andPHC10 are the polyherbal combination treated groups.</p>
Full article ">Figure 3
<p>Heart weight/body weight ratio. All values are expressed as mean ± SD (<italic>n</italic> = 6) analyzed by one-way ANOVA followed by Tukey’s <italic>t</italic>-test. D-HFD-C was compared with NC (<sup>#</sup> <italic>p</italic> &lt; 0.0001), and the result was found to be highly significantly different. The different treatment groups were compared with D-HFD-C, and the results were found to be different at the significance levels and **** <italic>p</italic> &lt; 0.0001. NC is normal control; D-HFD-C is diabetic high-fat diet control group; PHC6 and PHC10 are polyherbal combination treated groups.</p>
Full article ">Figure 4
<p>Cardiac biomarker enzymes. All values are expressed as mean ± SD (<italic>n</italic> = 6) analyzed by one-way ANOVA followed by Tukey’s <italic>t</italic>-test. D-HFD-C was compared with NC (<sup>#</sup> <italic>p</italic> &lt; 0.0001), and the values were found to be highly significantly different. The different treatment groups were compared with the D-HFD-C group, with the values expressed in log<sub>10</sub> scale on the Y-axis, and the results for each parameter (ALT, CK-MB and LDH) were found to be different at the following significance levels: <sup>d</sup> <italic>p</italic> &lt; 0.05; <sup>c</sup> <italic>p</italic> &lt; 0.01; <sup>a</sup> <italic>p</italic> &lt; 0.0001 from the respective disease control groups. NC is normal control; D-HFD-C is diabetic high-fat diet control group; PHC6 and PHC10 are polyherbal combination treated groups.</p>
Full article ">Figure 5
<p>Cardiac marker activity. All values are expressed as mean ± SD (<italic>n</italic> = 6) analyzed by one-way ANOVA followed by Tukey’s <italic>t</italic>-test. D-HFD-C was compared with NC (<sup>#</sup> <italic>p</italic> &lt; 0.0001), and the values were found to be highly significantly different. The different treatment groups were compared with D-HFD-C, with the values expressed in log<sub>10</sub> scale on the Y-axis, and the results for each parameter (MCAD, PDH and TG) were found to be different at the following significance levels: <sup>d</sup> <italic>p</italic> &lt; 0.05; <sup>c</sup> <italic>p</italic> &lt; 0.01; <sup>b</sup> <italic>p</italic> &lt; 0.001; <sup>a</sup> <italic>p</italic> &lt; 0.0001 from the respective disease control groups. NC is normal control; D-HFD-C is diabetic high-fat diet control group; PHC6 and PHC10 are polyherbal combination treated groups.</p>
Full article ">Figure 6
<p>All values are expressed as mean ± SD (<italic>n</italic> = 6) analyzed by one-way ANOVA followed by Tukey’s <italic>t</italic>-test. D-HFD-C was compared with NC (<sup>#</sup> <italic>p</italic> &lt; 0.0001), and the result was found to be highly significantly different. The different treatment groups were compared with D-HFD-C, and the results were found to be different at the significance levels ** <italic>p</italic> &lt; 0.01 and **** <italic>p</italic> &lt; 0.0001. NC is normal control; D-HFD-C is diabetic high fat diet control group; PHC6 and PHC10 are polyherbal combination treated groups.</p>
Full article ">Figure 7
<p>Western Blot α/β Myosin Heavy Chain (MHC) expression. All values are expressed as Mean ± SD (n = 6). The values were analysed bt one way ANOVA &amp; followed by Tukey’s <italic>t</italic>-test and were found to be significantly different at (a,b) <italic>p</italic> &lt; 0.05 when D-HFD-C was compared with NC &amp; all other Treatment groups were compared with D-HFD-C. Where, NC is normal control; D-HFD-C is Diabetic High Fat Diet Control; PHC-6 &amp; PHC-10 are polyherbal combination treated groups.</p>
Full article ">Figure 8
<p>Troponin-T Test.</p>
Full article ">Figure 9
<p>(<bold>a</bold>) Gross Morphology of intact heart from different treatment groups. (<bold>b</bold>) Gross Morphology of Heart section from different treatment groups. (<bold>c</bold>) Gross Morphology values of different treatment groups. All values are expressed as mean ±SD (<italic>n</italic> = 6) analyzed by one-way ANOVA followed by Tukey’s <italic>t</italic>-test. D-HFD-C was compared with NC (<sup>#</sup> <italic>p</italic> &lt; 0.0001), and the values were found to be highly significantly different. The different treatment groups were compared with D-HFD-C, and the results for each parameter (LV, RV and IVS) were found to be different at the following significance levels: <sup>b</sup> <italic>p</italic> &lt; 0.001; <sup>a</sup> <italic>p</italic> &lt; 0.0001 from the respective disease control groups. NC is normal control; D-HFD-C is diabetic high-fat diet control group; PHC6 and PHC10 are polyherbal combination treated groups; LV is left ventricular wall thickness; RV is right ventricular wall thickness; IVS is intra-ventricular septum thickness).</p>
Full article ">Figure 10
<p>Histopathology of cardiac tissues from different treatment groups. Where, (<bold>a</bold>). Normal Control; (<bold>b</bold>). is D-HFD-C; (<bold>c</bold>). Olive Oil-C; (<bold>d</bold>). PHC-6 treated; (<bold>e</bold>). PHC10 treated; (<bold>f</bold>). Metformin treated; (<bold>g</bold>). Carvedilol treated.</p>
Full article ">Figure 11
<p>Fasting blood glucose level for OGTT. All values are expressed as mean ± SD (<italic>n</italic> = 6) analyzed by one-way ANOVA followed by Tukey’s <italic>t</italic>-test. D-HFD-C was compared with NC (<sup>#</sup> <italic>p</italic> &lt; 0.0001), and the values were found to be highly significantly different. The different treatment groups were compared with D-HFD-C and the results were found to be different at the following significance levels: <sup>c</sup> <italic>p</italic> &lt; 0.01; <sup>b</sup> <italic>p</italic> &lt; 0.001; <sup>a</sup> <italic>p</italic> &lt; 0.0001 from the respective disease control groups. NC is normal control; D-HFD-C is diabetic high-fat diet control group; PHC6 and PHC10 are the polyherbal combination treated groups.].</p>
Full article ">
13 pages, 4004 KiB  
Article
TinoTranscriptDB: A Database of Transcripts and Microsatellite Markers of Tinospora cordifolia, an Important Medicinal Plant
by Rakesh Singh, Ajay Kumar Mahato, Akshay Singh, Rajesh Kumar, Amit K. Singh, Sundeep Kumar, Soma S. Marla, Ashok Kumar and Nagendra K. Singh
Genes 2022, 13(8), 1433; https://doi.org/10.3390/genes13081433 - 12 Aug 2022
Cited by 8 | Viewed by 3053
Abstract
Tinospora cordifolia, commonly known as “Giloe” in India, is a shrub belonging to the family Menispermaceae. It is an important medicinal plant known for its antipyretic, anti-inflammatory, antispasmodic, and antidiabetic properties and is used in the treatment of jaundice, gout, and rheumatism. [...] Read more.
Tinospora cordifolia, commonly known as “Giloe” in India, is a shrub belonging to the family Menispermaceae. It is an important medicinal plant known for its antipyretic, anti-inflammatory, antispasmodic, and antidiabetic properties and is used in the treatment of jaundice, gout, and rheumatism. Despite its economic importance, the limited information related to its genomic resources prohibits its judicious exploitation through molecular breeding or biotechnological approaches. In this study, we generated a meta-transcriptome assembly of 43,090 non-redundant transcripts by merging the RNASeq data obtained from Roche 454 GS-FLX, and Illumina platforms, and report the first transcriptome-based database for simple sequence repeats and transcription factors (“TinoTranscriptDB” (Tinospora cordifolia Transcriptome Database)). We annotated 26,716 (62%) of the total transcripts successfully from National Center for Biotechnology Information non-redundant protein (NCBI-NR), gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Swiss-Prot, and Pfam databases. This database contains information of 2620 perfect simple sequence repeats (P-SSRs) with a relative abundance of 340.12 (loci/Mb), and relative density of 6309.29 (bp/Mb). Excluding mono-nucleotides, the most abundant SSR motifs were tri-nucleotides (54.31%), followed by di-nucleotides (37.51%), tetra-nucleotides (4.54%), penta-nucleotides (3.16%) and hexa-nucleotides (0.45%). Additionally, we also identified 4,311 transcription factors (TFs) and categorized them into 55 sub-families. This database is expected to fill the gap in genomic resource availability in T. cordifolia and thus accelerate molecular breeding and related functional and other applied studies aimed towards genetic improvements of T. cordifolia and related species. Full article
(This article belongs to the Section Bioinformatics)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Three-level database schema architecture used for the construction of TinoTranscriptDB.</p>
Full article ">Figure 2
<p>Process flow diagram and tools used for the transcriptome SSR marker identification, primer designing, annotation and transcription factor categorization.</p>
Full article ">Figure 3
<p>Functional classification of transcripts based on GO terms, distributed in three major categories: molecular function, biological process, and cellular component.</p>
Full article ">Figure 4
<p>Pie-chart distribution of <span class="html-italic">T. cordifolia</span> 4311 transcripts in to 55 TF categories based on the BlastX search against the PlantTFDB.</p>
Full article ">Figure 5
<p>Line graph coverage graph of identified 4311 <span class="html-italic">T. cordifolia</span> transcripts categorized into 55 different TF categories based on minimum, maximum and average transcript length of each TFs category.</p>
Full article ">Figure 6
<p>Screenshot of the TinoTranscriptDB showing SSR and primer searching using different search options, (1) arrow shows perfect SSR search criteria on SSR search page; (2) arrow shows search for SSR di to hexa types; (3) arrow shows Primer Details link of particular SSR; (4) arrow shows Annotation Details link of particular SSR with annotation information; (5) arrow shows Sequences link of that TF category in a fasta sequence file; (6) arrow shows GO Id in fasta sequence file.</p>
Full article ">Figure 7
<p>Screenshot of the TinoTranscriptDB showing transcript annotation searching with the download option for several sequences, (1) arrow shows Gene ontology search by the GO Id; (2) arrow shows by click on the particular GO Id detailed information on a separate page; (3) arrow shows BLASTX search by the annotation keyword on a separate page.</p>
Full article ">
Back to TopTop